Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Novel First-in-Class Drug ONC201 As a Post-Transplant Maintenance for AML and MDS: A Phase I Trial in Progress

Vijaya Raj Bhatt, Christopher Wichman, Alyssa C. Bouska, Lori Maness, Zaid S. Al-Kadhimi, Javeed Iqbal, James E. Talmadge, Krishna Gundabolu

Blood (2022) 140 (Supplement 1): 12918–12919.

https://doi.org/10.1182/blood-2022-156316

Published: 2022

Journal Articles

Immunologic and Clinical Responses To a CD20-Targeted Immunocytokine, DI-Leu16-IL2, In Relapsed Non-Hodgkin Lymphoma

Ryotaro Nakamura, Robert Chen, MD, Joycelynne Palmer, PhD, Karl Gaal, MD, Auayporn Nademanee, MD, Leslie Popplewell, MD, James E. Talmadge, PhD, Stephen Gillies, PhD, David Colcher, PhD, Stephen J. Forman, MD, Andrew Raubitschek, MD

Blood (2013) 122 (21): 1808.

https://doi.org/10.1182/blood.V122.21.1808.1808

Published: 2013

Journal Articles

Significant Expansion of Myeloid Derived Suppressor Cells in Patients with High- Risk Breast Cancer Treated with Dose Dense Adjuvant Chemotherapy

James E Talmadge, Elizabeth Reed, MD, Kenneth Cowan, Dmitry Gabrilovich, Phyllis Warkentin, William E. Janssen, PhD, James Wisecarver, James Anderson, Mary Mailliard, Sarah Maas, Orhan Turken, Uger Coskun

Blood (2008) 112 (11): 4653.

https://doi.org/10.1182/blood.V112.11.4653.4653

Published: 2008

Journal Articles

Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice

Yasushi Sawanobori, Satoshi Ueha, Makoto Kurachi, Takeshi Shimaoka, James E. Talmadge, Jun Abe, Yusuke Shono, Masahiro Kitabatake, Kazuhiro Kakimi, Naofumi Mukaida, Kouji Matsushima

Blood (2008) 111 (12): 5457–5466.

https://doi.org/10.1182/blood-2008-01-136895

Published: 2008

Includes: Supplemental data

Journal Articles

Effect of T Cell Recovery on Overall Survival (OS) Following Pentostatin Conditioning for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).

James E. Talmadge, PhD, Ugur Coskun, PhD, Sarah Maas, MS, Orhan Turken, MD, Ziviko S. Pavletic, MD, Charles A. Kuszynski, PhD, Marcel Devetten, MD, Laura R. Schafer, MS, Lori Zobel, BS, Robert G. Bociek, MD

Blood (2007) 110 (11): 2994.

https://doi.org/10.1182/blood.V110.11.2994.2994

Published: 2007

Journal Articles

Mechanism of Alemtuzumab Depletion of T Cells in Stem Cell Products.

Dumrul Gulen, PhD, Robert G. Bociek, MD, Ugur Coskun, MD, Marcel P. Devetten, MD, James E. Talmadge, PhD

Blood (2006) 108 (11): 5176.

https://doi.org/10.1182/blood.V108.11.5176.5176

Published: 2006

Journal Articles

Differential T Cell Suppression by Two Different Pentostatin Conditioning Protocols for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).

Ugur Coskun, MD, Robert G. Bociek, MD, Zivko S. Pavletic, MD, Charlie Kuszynski, PhD, Marcel Devetten, MD, Laura Shafer, Lori Zobel, James E. Talmadge, PhD

Blood (2006) 108 (11): 5373.

https://doi.org/10.1182/blood.V108.11.5373.5373

Published: 2006

Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) for Hematologic Malignancies (HM) Using Pentostatin/Low-Dose Total Body Irradiation (TBI).

R. Gregory Bociek, MD, MSc, James E. Talmadge, PhD, James C. Lynch, PhD, Charles A. Enke, MD, Charles A. Kuszynski, PhD, Philip J. Bierman, MD, Julie M. Vose, MD, James O. Armitage, MD, Marcel P. Devetten, MD, Lori J. Maness, MD, Timothy R. McGuire, PhD, James L. Wisecarver, MD, Shantaram S. Joshi, PhD, Zivko S. Pavletic, MD

Blood (2005) 106 (11): 3671.

https://doi.org/10.1182/blood.V106.11.3671.3671

Published: 2005

Journal Articles

Intratumoral, Injection of Adenoviral Flt3 Ligand Has Therapeutic Activity in Association with Increased Intratumoral Levels of T Cells but Not Dendritic Cells.

James E. Talmadge, PhD, Scott G. Kurz, MSc, Randy R. Fields, BS, Devendra K. Agrawal, PhD, Rakesh K. Singh, PhD, Drake M. LaFace, PhD, Abdel-kader E. Ashour, PhD, Lora R. Shafer, BS, Joyce E. Solhwim, PhD

Blood (2004) 104 (11): 5280.

https://doi.org/10.1182/blood.V104.11.5280.5280

Published: 2004

Journal Articles

Donor immune reconstitution after liver–small bowel transplantation for multiple intestinal atresia with immunodeficiency

Richard K. Gilroy, Peter F. Coccia, James E. Talmadge, Lori I. Hatcher, Samuel J. Pirruccello, Byers W. Shaw, Jr, Ronald J. Rubocki, Debra L. Sudan, Alan N. Langnas, Simon P. Horslen

Blood (2004) 103 (3): 1171–1174.

https://doi.org/10.1182/blood-2003-04-1187

Published: 2004

NARROW

Novel First-in-Class Drug ONC201 As a Post-Transplant Maintenance for AML and MDS: A Phase I Trial in Progress

Immunologic and Clinical Responses To a CD20-Targeted Immunocytokine, DI-Leu16-IL2, In Relapsed Non-Hodgkin Lymphoma

Significant Expansion of Myeloid Derived Suppressor Cells in Patients with High- Risk Breast Cancer Treated with Dose Dense Adjuvant Chemotherapy

Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice

Effect of T Cell Recovery on Overall Survival (OS) Following Pentostatin Conditioning for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).

Mechanism of Alemtuzumab Depletion of T Cells in Stem Cell Products.

Differential T Cell Suppression by Two Different Pentostatin Conditioning Protocols for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).

Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) for Hematologic Malignancies (HM) Using Pentostatin/Low-Dose Total Body Irradiation (TBI).

Intratumoral, Injection of Adenoviral Flt3 Ligand Has Therapeutic Activity in Association with Increased Intratumoral Levels of T Cells but Not Dendritic Cells.

Donor immune reconstitution after liver–small bowel transplantation for multiple intestinal atresia with immunodeficiency

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only